CA2110376A1 - Preparation pharmaceutique pour lavement - Google Patents

Preparation pharmaceutique pour lavement

Info

Publication number
CA2110376A1
CA2110376A1 CA002110376A CA2110376A CA2110376A1 CA 2110376 A1 CA2110376 A1 CA 2110376A1 CA 002110376 A CA002110376 A CA 002110376A CA 2110376 A CA2110376 A CA 2110376A CA 2110376 A1 CA2110376 A1 CA 2110376A1
Authority
CA
Canada
Prior art keywords
pharmaceutical
suspensions
enema preparation
enema
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002110376A
Other languages
English (en)
Other versions
CA2110376C (fr
Inventor
Adrianus J. Wittebrood
Adrianus Petrus De Jong
Jan Bron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Altana Pharma BV
Original Assignee
Adrianus J. Wittebrood
Adrianus Petrus De Jong
Jan Bron
Byk Nederland B.V.
Altana Pharma B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19914122337 external-priority patent/DE4122337A1/de
Application filed by Adrianus J. Wittebrood, Adrianus Petrus De Jong, Jan Bron, Byk Nederland B.V., Altana Pharma B.V. filed Critical Adrianus J. Wittebrood
Publication of CA2110376A1 publication Critical patent/CA2110376A1/fr
Application granted granted Critical
Publication of CA2110376C publication Critical patent/CA2110376C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
CA002110376A 1991-06-07 1992-06-05 Preparation pharmaceutique pour lavement Expired - Fee Related CA2110376C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH1690/91-4 1991-06-07
CH169091 1991-06-07
DE19914122337 DE4122337A1 (de) 1991-07-05 1991-07-05 Pharmazeutische zubereitung
DEP4122337.3 1991-07-05
PCT/EP1992/001274 WO1992021324A1 (fr) 1991-06-07 1992-06-05 Preparation pharmaceutique pour clystere

Publications (2)

Publication Number Publication Date
CA2110376A1 true CA2110376A1 (fr) 1992-12-10
CA2110376C CA2110376C (fr) 2003-02-11

Family

ID=25688396

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002110376A Expired - Fee Related CA2110376C (fr) 1991-06-07 1992-06-05 Preparation pharmaceutique pour lavement

Country Status (12)

Country Link
US (1) US5352681A (fr)
EP (2) EP0517274A1 (fr)
AT (1) ATE121934T1 (fr)
AU (1) AU1907992A (fr)
CA (1) CA2110376C (fr)
CZ (1) CZ280758B6 (fr)
DE (1) DE59202096D1 (fr)
DK (1) DK0586488T3 (fr)
ES (1) ES2074889T3 (fr)
HU (1) HU213229B (fr)
SK (1) SK279195B6 (fr)
WO (1) WO1992021324A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999016454A1 (fr) * 1997-09-26 1999-04-08 Medeva Europe Limited Composition pharmaceutique pour le traitement d'une maladie intestinale inflammatoire (ibd)
IT1301947B1 (it) * 1998-07-28 2000-07-20 Chiesi Farma Spa Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa
US6319513B1 (en) 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
TWI249519B (en) 2000-08-29 2006-02-21 Nobex Corp Immunoregulatory compounds and derivatives and methods of treating diseases therewith
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
FR2835522B1 (fr) * 2002-02-06 2006-04-07 Robert Vachy Preparation pour composes sensibles a l'oxydation et son procede de fabrication
HUE028158T2 (en) 2004-07-07 2016-12-28 Biocon Ltd Synthesis of bound immunoregulatory compounds
US7645801B2 (en) * 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
US9662481B2 (en) 2008-10-07 2017-05-30 Cristcot Llc Method and apparatus for inserting a rectal suppository
US8192393B2 (en) * 2008-10-07 2012-06-05 Christcot Medical Company Method and apparatus for inserting a rectal suppository
BR112015008689A2 (pt) 2012-10-19 2017-07-04 Cristcot Inc método para fabricar um supositório, kit, supositório e aparelho para inserir um supositório
CN109152912B (zh) 2016-05-12 2022-01-18 克里斯科特有限责任公司 一次性栓剂插入装置及方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3658552A (en) * 1969-05-22 1972-04-25 Gen Foods Corp Clouding agent
US4034079A (en) * 1974-02-12 1977-07-05 Marten Leonard Schoonman Self-sanitizing plastic
US3992215A (en) * 1975-05-08 1976-11-16 Eli Lilly And Company Pharmaceutical suspension for opaqing empty gelatin capsules
US4137092A (en) * 1976-02-06 1979-01-30 Cumpston Edward H Dispersion or suspension of solid phase in liquid phase
USRE34145E (en) * 1982-09-02 1992-12-15 Union Carbide Chemicals & Plastics Technology Corporation Encapsulating finely divided solid particles in stable suspensions
US4771086A (en) * 1982-09-02 1988-09-13 Union Carbide Corporation Encapsulating finely divided solid particles in stable suspensions
US4664256A (en) 1983-09-06 1987-05-12 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
US4657900A (en) 1983-09-27 1987-04-14 Rowell Laboratories Pharmaceutical article of manufacture comprising a bisulfite stabilized aqueous solution of 5-aminosalicylic acid and method
US4564518A (en) * 1984-04-26 1986-01-14 Rosenbaum Joseph G Ophthamological method for testing tear flow and composition for use in same
US4933330A (en) * 1987-04-01 1990-06-12 Dak-Laboratoriet Benzoic acid derivatives and use thereof
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
US5010069A (en) * 1989-05-15 1991-04-23 Marion Laboratories, Inc. Stable liquid form of 5-aminosalicylic acid
FR2647344B1 (fr) * 1989-05-25 1995-06-02 Physiopharm Sarl Mousse aerosol a usage rectal
US5290352A (en) * 1991-11-11 1994-03-01 Bayer Ag Process for the preparation of a pigment suspension
JP3388592B2 (ja) * 1992-03-05 2003-03-24 テイカ株式会社 紫外線遮蔽用の鱗片状顔料、その製造方法および上記紫外線遮蔽用の鱗片状顔料を配合した化粧料

Also Published As

Publication number Publication date
EP0517274A1 (fr) 1992-12-09
US5352681A (en) 1994-10-04
DK0586488T3 (da) 1995-09-04
SK279195B6 (sk) 1998-07-08
HU213229B (en) 1997-03-28
CA2110376C (fr) 2003-02-11
EP0586488A1 (fr) 1994-03-16
AU1907992A (en) 1993-01-08
HUT65898A (en) 1994-07-28
DE59202096D1 (de) 1995-06-08
SK133793A3 (en) 1994-05-11
CZ280758B6 (cs) 1996-04-17
ATE121934T1 (de) 1995-05-15
EP0586488B1 (fr) 1995-05-03
ES2074889T3 (es) 1995-09-16
CZ266393A3 (en) 1994-04-13
WO1992021324A1 (fr) 1992-12-10

Similar Documents

Publication Publication Date Title
HK1011987A1 (en) Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines
CA2110376A1 (fr) Preparation pharmaceutique pour lavement
AU7002687A (en) Quinolonecarboxylic acid derivatives their preparation and use as antibacterials
IL103746A0 (en) Acetic acid derivatives,their preparation and pharmaceutical compositions containing them
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3580616D1 (de) Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
CA2110161A1 (fr) Preparations transdermiques de medetomidine
IL103437A0 (en) Cyclohexaneacetic acid derivatives,their preparation and pharmaceutical compositions containing them
RU93044489A (ru) Производные хиноксалина, их получение, лекарственные средства на их основе
IL103329A0 (en) Imidazole-5-carboxylic acid acylals,their preparation and pharmaceutical compositions containing them
IL101771A0 (en) Carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
CA2100126A1 (fr) Complexes d'inclusion d'acide 5,10-methylenetetrahydrofolique-cyclodextrine
CA2047802A1 (fr) Compositions pharmaceutiques
IL102362A0 (en) 4-amino-3-hydroxycarboxylic acid derivatives,their production and pharmaceutical compositions containing them
RU92004562A (ru) Новые цефалоспорины, имеющие в положении 7 замещенный оксииминный радикал, метод их получения и их использование в качестве медикаментов, фармацевтический состав на их основе
ZA811386B (en) 7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives, their use and preparation
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE32882T1 (de) Phenylnonatetraensaeurederivate, ihre herstellung und pharmazeutische praeparate mit diesen derivaten.
WO1989000422A3 (fr) Derives d'acide thiosulfinique, leur utilisation dans le traitement de maladies inflammatoires et medicaments les contenant
AU476979B2 (en) 4'-alkoxyalkyleneoxy-5-benzylpyrimidines, their preparation and pharmaceutical compositions thereof
CA1029026A (fr) Derives de la n2-dansyl-l-arginine et sels acides d'addition a effet pharmacologique acceptable
FI932396A0 (fi) Foerfarande foer framstaellning av en dubbelskyddad 2,3-hydroximetylcyklobutanol
DE3774849D1 (de) Alkylaminoalkylisch oder heterocyclylalkylisch an den triazolring substituierte 8-azaxanthine, ihre physiologisch vertraeglichen salze, ihre pharmazeutische zubereitungen mit antibronchospastischer wirkung und verfahren zu ihrer herstellung.
Green Detailed sedimentology of the Bowser Lake group, northern Bowser basin, north-central British Columbia.
IL104079A0 (en) Benzimidazolesulfonic acid derivatives,their preparation and their use as microbicides

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed